Inventor · disambiguated record
Marion T. Kasaian
Also filed as: KASAIAN MARION · KASAIAN MARION T · KASAIAN MARION TERESA
5 granted patents·9 pending applications·264 citations·filing 2002–2023
84Inventor score
Top patents by PatentIndex Score
14 records- 0197US7501121B2IL-13 binding agentsWYETH CORP·Filed 2005·Granted Mar 10, 2009·112 cites·41 claims
- 0296US7615213B2Antibodies against human interleukin-13 and pharmaceutical compositions thereofWYETH CORP·Filed 2005·Granted Nov 10, 2009·100 cites·85 claims
- 0387US8221752B2Antibodies against human interleukin-13 and uses thereforKASAIAN MARION T·Filed 2009·Granted Jul 17, 2012·18 cites·2 claims
- 0486US7198789B2Methods and compositions for modulating interleukin-21 receptor activityGENETICS INST LLC·Filed 2002·Granted Apr 3, 2007·32 cites·66 claims
- 0576US7943342B2Nucleic acids encoding IL-13 binding agentsWYETH LLC·Filed 2009·Granted May 17, 2011·2 cites·58 claims
- 0659US2024117030A1Multispecific antibodies and uses thereofPFIZER·Filed 2023·Application pending·0 cites
- 0755US2008241098A1Antagonizing interleukin-21 receptor activityWYETH CORP·Filed 2007·Application pending·0 cites
- 0850US2011262435A1Il-13 binding agentsWYETH LLC·Filed 2011·Application pending·0 cites
- 0947US2006039902A1Antagonizing interleukin-21 receptor activityYOUNG DEBORAH A·Filed 2005·Application pending·0 cites
- 1046US2004016010A1IL-21 receptor knockout animal and methods of use thereofFiled 2003·Application pending·0 cites
- 1144US2010223685A1Il-21 receptor knockout animal and methods of use thereofKASAIAN MARION·Filed 2010·Application pending·0 cites
- 1241US2006024268A1Modulation of immunoglobulin production and atopic disordersWYETH CORP·Filed 2005·Application pending·0 cites
- 1340US2005164323A1Methods of treating asthmaWYETH CORP·Filed 2004·Application pending·0 cites
- 1440US2009098142A1Methods and compositions for treating and monitoring treatment of IL-13-associated disordersKASAIAN MARION T·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →